HHS, Inflammatix To Develop Test Distinguishing Bacterial, Viral Infections

HHS, as part of its bid to combat antimicrobial resistance, is partnering with Inflammatix Inc. to develop a diagnostic test that reads genetic expression patterns in the immune system to determine whether an infection is bacterial or viral. The department hopes the new diagnostic technique will also determine the severity of an infection within minutes. The technology, known as host-response testing, will be developed under a $6 million, 14-month contract between the Biomedical Advanced Research and Development Authority ( BARDA...